Dr. Ali Khalil, MD

Dr. Khalil practices at Medical City Dallas Hospital in Dallas, Texas, part of HCA Healthcare.

Dr. Khalil's NPI, 1417186578, was assigned on July 10, 2009. Dr. Khalil graduated from Jordan University of Science and Technology FOM in 2007. Dr. Khalil holds Texas license R7504.

Dr. Khalil's primary practice is Medical City Dallas Hospital, at 7777 Forest Lane, Dallas, TX 75230 in Dallas County. The practice phone is (972) 566-6222.

Dr. Khalil's primary practice is Medical City Dallas Hospital in Dallas, Texas, part of HCA Healthcare. Dr. Khalil is also affiliated with Baylor Scott & White All Saints Medical Center - Fort Worth. The medical group on file is Dallas Nephrology Associates. Dmand AI also links Dr. Khalil to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Khalil practices, 3 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Khalil's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Khalil is board certified in nephrology by the American Board of Internal Medicine. Dmand AI has Dr. Khalil's licenses on file in 5 states: Texas, Maryland, Wisconsin, Indiana and Illinois.

Dmand AI lists acute kidney failure, chronic anemia and parathyroid gland disorder among the conditions Dr. Khalil treats.

CMS data shows 2,248 Medicare services from Dr. Khalil across 7 procedure codes in 2024, for 382 Medicare patients. Medicare paid $163,287 for them.

CMS counts 382 Medicare patients who saw Dr. Khalil in 2024. The largest group is under 65, with 182 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 25% are also on Medicaid. Their average risk score is 5.11, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Khalil's median patient age at 58, with 42% women.

In 2024, Dr. Khalil wrote 1,208 Medicare Part D claims for 224 patients. 93% of them were for generic drugs. CMS names the drug for 930 of them, across 27 drugs with 11 or more claims each, at $69,446 in total drug cost. In 2023, CMS named 1,097 claims across 28 drugs.

Dr. Khalil accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 8 papers to Dr. Khalil, published from 2010 to 2020. 2015 was the busiest year, with 2. The most frequent topics are Kidney Transplantation, Graft Rejection and Glomerular Filtration Rate. Dr. Khalil has published most often in Clin Transplant. Dr. Khalil's most frequent co-authors are Muhammad Ahmad Mujtaba, MD, John Abram Powelson, MD and Asif Aziz Sharfuddin, MD.

CMS Open Payments shows 32 general payments to Dr. Khalil from 16 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 87% of the total. Relypsa, Inc. paid the most, $251.

Dmand AI lists 2 awards for Dr. Khalil, most recently Best Clinical Science Research Award in 2016.

Dr. Khalil graduated from Jordan University of Science and Technology FOM in 2007. Dr. Khalil is a member of ACP, AMA, American Society of Nephrology, American Society of Transplant, NKF and Renal Physicians Network.

Dr. Khalil is in network with 23 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.